"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","24/36","481/2914",1.78196557721708e-11,7.76936991666646e-09,5.40216932882651e-09,"AKT2/EGFR/JUN/MAPK11/MAPK14/SFN/SMAD2/TP53/WWTR1/YAP1/ITCH/NR4A1/PPP2CA/SMAD3/SRC/E2F1/CREB1/HNF4A/GATA2/SP1/TEAD1/FOXO1/NR2F1/RUNX2",24
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","24/36","499/2914",4.03945339756713e-11,8.80600840669634e-09,6.12296093947018e-09,"AKT2/EGFR/JUN/MAPK11/MAPK14/SFN/SMAD2/TP53/WWTR1/YAP1/ITCH/NR4A1/PPP2CA/SMAD3/SRC/E2F1/CREB1/HNF4A/GATA2/SP1/TEAD1/FOXO1/NR2F1/RUNX2",24
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","17/36","397/2914",9.93575590378155e-07,0.000120372410037227,8.36968954387284e-05,"AKT2/EGFR/JUN/MAPK11/MAPK14/SMAD2/MAPK8/RHOA/ROCK2/SMAD3/SRC/STAT3/E2F1/CREB1/HNF4A/GATA2/FOXO1",17
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","6/36","30/2914",1.10433403703878e-06,0.000120372410037227,8.36968954387284e-05,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","9/36","99/2914",1.8415506208275e-06,0.000160583214136158,0.000111656121852278,"JUN/MAPK11/MAPK14/TP53/MAPK8/STAT3/E2F1/ETS2/SP1",9
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/36","10/2914",3.9129023937883e-06,0.000284337573948617,0.000197704542001935,"JUN/MAPK11/MAPK14/MAPK8",4
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","4/36","12/2914",9.06179583377549e-06,0.000564420426218016,0.000392450706786066,"WWTR1/YAP1/TEAD1/RUNX2",4
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","6/36","44/2914",1.15889182554697e-05,0.000631596044923096,0.000439159007575692,"JUN/MAPK11/MAPK14/TP53/MAPK8/E2F1",6
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","7/36","70/2914",1.63442854391571e-05,0.000791789827941388,0.000550544351634765,"MAPK11/MAPK14/PPP2CA/RHOA/SRC/STAT3/CREB1",7
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","5/36","29/2914",2.07108409610629e-05,0.000870255988045622,0.000605103149582663,"AKT2/SFN/TP53/MAPK8/E2F1",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","6/36","49/2914",2.19559996983987e-05,0.000870255988045622,0.000605103149582663,"AKT2/SFN/TP53/MAPK8/STAT3/E2F1",6
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","10/36","172/2914",2.63054235695493e-05,0.000955763723026959,0.000664558069125457,"AKT2/EGFR/JUN/TP53/NR4A1/PPP2CA/SRC/EGR1/CREB1/FOXO1",10
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","6/36","53/2914",3.4781624488265e-05,0.00116652217514489,0.000811101850414602,"TP53/WWTR1/YAP1/SMAD3/SRC/TEAD1",6
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/36","19/2914",6.67047758069556e-05,0.00207110960520954,0.00144007621028572,"WWTR1/YAP1/SRC/RUNX2",4
"R-HSA-450294","R-HSA-450294","MAP kinase activation","6/36","60/2914",7.1253770821429e-05,0.00207110960520954,0.00144007621028572,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","7/36","89/2914",7.93791815290527e-05,0.00216308269666669,0.00150402659739258,"MAPK11/MAPK14/PPP2CA/RHOA/SRC/STAT3/CREB1",7
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","10/36","201/2914",0.000101463554200856,0.00249397922925827,0.00173410434096181,"AKT2/EGFR/JUN/TP53/NR4A1/PPP2CA/SRC/EGR1/CREB1/FOXO1",10
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","6/36","64/2914",0.000102962445244608,0.00249397922925827,0.00173410434096181,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","13/36","347/2914",0.000137384168230592,0.00315260512360726,0.00219205764268201,"AKT2/EGFR/MAPK11/MAPK14/YAP1/ITCH/PPP2CA/RHOA/ROCK2/SRC/STAT3/STAT6/CREB1",13
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/36","23/2914",0.000147107648112554,0.0031787847280666,0.00221026074766582,"TP53/E2F1/ETS2/SP1",4
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/36","24/2914",0.000174978975856877,0.0031787847280666,0.00221026074766582,"MAPK11/MAPK14/PPP2CA/CREB1",4
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/36","24/2914",0.000174978975856877,0.0031787847280666,0.00221026074766582,"SMAD2/WWTR1/SMAD3/SP1",4
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/36","24/2914",0.000174978975856877,0.0031787847280666,0.00221026074766582,"AKT2/NR4A1/CREB1/FOXO1",4
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","4/36","24/2914",0.000174978975856877,0.0031787847280666,0.00221026074766582,"WWTR1/YAP1/SRC/RUNX2",4
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","7/36","104/2914",0.000214189969367291,0.00373547306576555,0.00259733520748546,"EGFR/JUN/TP53/ITCH/SMAD3/E2F1/CREB1",7
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/36","11/2914",0.000267102106632689,0.00416091059292332,0.00289314884297903,"AKT2/HNF4A/FOXO1",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/36","11/2914",0.000267102106632689,0.00416091059292332,0.00289314884297903,"AKT2/SFN/FOXO1",3
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","5/36","49/2914",0.000278177392239492,0.00416091059292332,0.00289314884297903,"AKT2/SFN/SMAD2/SMAD3/FOXO1",5
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/36","27/2914",0.000281451613557831,0.00416091059292332,0.00289314884297903,"STAT3/E2F1/CREB1/GATA2",4
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","6/36","78/2914",0.000311239804656174,0.00416091059292332,0.00289314884297903,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","6/36","78/2914",0.000311239804656174,0.00416091059292332,0.00289314884297903,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","6/36","78/2914",0.000311239804656174,0.00416091059292332,0.00289314884297903,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","9/36","187/2914",0.000314931306345113,0.00416091059292332,0.00289314884297903,"JUN/MAPK11/MAPK14/TP53/MAPK8/STAT3/E2F1/ETS2/SP1",9
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","9/36","189/2914",0.000341292871506399,0.00437657917578793,0.00304310671807563,"JUN/MAPK11/MAPK14/TP53/MAPK8/STAT3/E2F1/ETS2/SP1",9
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","12/36","332/2914",0.000386254729414575,0.00481163034356442,0.00334560487432774,"JUN/MAPK11/MAPK14/TP53/MAPK8/PPP2CA/SMAD3/STAT3/STAT6/CREB1/FOXO1/IRF4",12
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","6/36","83/2914",0.000437363073571936,0.00521870069696145,0.00362864751502872,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-171007","R-HSA-171007","p38MAPK events","3/36","13/2914",0.000455157949035278,0.00521870069696145,0.00362864751502872,"MAPK11/MAPK14/SRC",3
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","6/36","84/2914",0.000466810383443799,0.00521870069696145,0.00362864751502872,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","6/36","84/2914",0.000466810383443799,0.00521870069696145,0.00362864751502872,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","6/36","85/2914",0.000497789527702254,0.00532830681325562,0.00370485843123519,"AKT2/MAPK11/MAPK14/RHOA/ROCK2/SRC",6
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","6/36","86/2914",0.000530355819263981,0.00532830681325562,0.00370485843123519,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","6/36","86/2914",0.000530355819263981,0.00532830681325562,0.00370485843123519,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","6/36","86/2914",0.000530355819263981,0.00532830681325562,0.00370485843123519,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","6/36","87/2914",0.000564565580583395,0.00532830681325562,0.00370485843123519,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","6/36","87/2914",0.000564565580583395,0.00532830681325562,0.00370485843123519,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","6/36","87/2914",0.000564565580583395,0.00532830681325562,0.00370485843123519,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/36","14/2914",0.000574381697759206,0.00532830681325562,0.00370485843123519,"SMAD2/SMAD3/FOXO1",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","6/36","90/2914",0.000677633851250899,0.00602955834990596,0.00419245003566614,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","6/36","90/2914",0.000677633851250899,0.00602955834990596,0.00419245003566614,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","3/36","15/2914",0.00071189327322705,0.00620770934253988,0.00431632131977664,"LATS2/WWTR1/YAP1",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","6/36","92/2914",0.000762307166761736,0.00651697891584543,0.00453136148663323,"AKT2/MAPK11/MAPK14/RHOA/ROCK2/SRC",6
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","4/36","35/2914",0.000782539897938386,0.00656129606732955,0.00456217592320355,"MAPK11/MAPK14/MAPK8/SRC",4
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","5/36","62/2914",0.000840534548509743,0.0068212591616225,0.00474293249287127,"AKT2/WWTR1/YAP1/SRC/RUNX2",5
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","7/36","130/2914",0.000844834850292695,0.0068212591616225,0.00474293249287127,"MAPK11/MAPK14/SFN/PPP2CA/RHOA/ROCK2/SRC",7
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/36","36/2914",0.00087263682553741,0.00691763010789656,0.00480994077999568,"SMAD2/WWTR1/SMAD3/SP1",4
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","5/36","63/2914",0.00090487829767314,0.00704512388902659,0.00489858928063655,"SMAD2/WWTR1/RHOA/SMAD3/SP1",5
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","6/36","97/2914",0.00101014648050584,0.00772673448246572,0.00537252421764879,"AKT2/EGFR/NR4A1/SRC/CREB1/FOXO1",6
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","10/36","268/2914",0.00107121001092536,0.0080525442200596,0.00559906502988209,"AKT2/EGFR/SMAD2/NR4A1/PPP2CA/SMAD3/SRC/STAT3/CREB1/FOXO1",10
"R-HSA-109581","R-HSA-109581","Apoptosis","6/36","101/2914",0.00124991985845638,0.00923669590316919,0.00642242496405777,"AKT2/SFN/TP53/MAPK8/STAT3/E2F1",6
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","6/36","103/2914",0.00138514020434235,0.0100653521515544,0.00699860313772975,"AKT2/SFN/TP53/MAPK8/STAT3/E2F1",6
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","3/36","19/2914",0.00146540024264294,0.0103050726740697,0.00716528471784663,"AKT2/PPP2CA/SRC",3
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/36","19/2914",0.00146540024264294,0.0103050726740697,0.00716528471784663,"SMAD2/SMAD3/FOXO1",3
"R-HSA-167044","R-HSA-167044","Signalling to RAS","3/36","20/2914",0.00170941526404401,0.0118302389702094,0.00822575766156517,"MAPK11/MAPK14/SRC",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","6/36","108/2914",0.00177249651119382,0.0120751324825079,0.00839603610565492,"AKT2/EGFR/JUN/SRC/CREB1/SP1",6
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","4/36","44/2914",0.00187429308808635,0.0123816937334189,0.00860919313187988,"AKT2/EGFR/RHOA/SRC",4
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","4/36","44/2914",0.00187429308808635,0.0123816937334189,0.00860919313187988,"EGFR/YAP1/ITCH/SRC",4
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","6/36","110/2914",0.00194871203151302,0.0124542553626196,0.00865964641341005,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","3/36","21/2914",0.00197745142169911,0.0124542553626196,0.00865964641341005,"MAPK11/MAPK14/PPP2CA",3
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","3/36","21/2914",0.00197745142169911,0.0124542553626196,0.00865964641341005,"RHOA/ROCK2/SRC",3
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","8/36","194/2914",0.00199953641142975,0.0124542553626196,0.00865964641341005,"AKT2/JUN/MAPK11/MAPK14/SFN/TP53/PPP2CA/E2F1",8
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/36","23/2914",0.00258880487565312,0.0158974496589403,0.0110537554364433,"JUN/TP53/E2F1",3
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/36","24/2914",0.00293363714705257,0.0175214492618482,0.0121829487866062,"AKT2/HNF4A/FOXO1",3
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","3/36","24/2914",0.00293363714705257,0.0175214492618482,0.0121829487866062,"AKT2/EGFR/CREB1",3
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","5/36","86/2914",0.00365116888414463,0.0212254617798274,0.0147584089632793,"YAP1/ITCH/SRC/GATA2/RUNX2",5
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","5/36","86/2914",0.00365116888414463,0.0212254617798274,0.0147584089632793,"SMAD2/WWTR1/RHOA/SMAD3/SP1",5
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","6/36","127/2914",0.00403809341226164,0.0231659043124484,0.0161076302317362,"JUN/MAPK11/MAPK14/MAPK8/PPP2CA/CREB1",6
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","3/36","27/2914",0.00413308759045488,0.0234029375251731,0.0162724432816269,"YAP1/ITCH/GATA2",3
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","3/36","29/2914",0.00507643460464245,0.0273250060200507,0.0189995213273168,"SRC/STAT3/STAT6",3
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/36","29/2914",0.00507643460464245,0.0273250060200507,0.0189995213273168,"JUN/TP53/E2F1",3
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/36","29/2914",0.00507643460464245,0.0273250060200507,0.0189995213273168,"AKT2/TP53/PPP2CA",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/36","29/2914",0.00507643460464245,0.0273250060200507,0.0189995213273168,"AKT2/TP53/PPP2CA",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/36","94/2914",0.00535816046268421,0.0284897312406136,0.0198093737259699,"TP53/STAT3/STAT6/FOXO1/IRF4",5
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","4/36","59/2914",0.00550760782707507,0.0287069035980018,0.0199603771999626,"AKT2/JUN/TP53/EGR1",4
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/36","30/2914",0.00559292438336913,0.0287069035980018,0.0199603771999626,"SFN/TP53/E2F1",3
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","5/36","95/2914",0.00560558645871642,0.0287069035980018,0.0199603771999626,"AKT2/MAPK11/MAPK14/TP53/PPP2CA",5
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","6/36","136/2914",0.00566237089318384,0.0287069035980018,0.0199603771999626,"AKT2/EGFR/JUN/SRC/CREB1/SP1",6
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/36","10/2914",0.00627585362200096,0.0310940020362775,0.0216201655877545,"PPP2CA/E2F1",2
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","2/36","10/2914",0.00627585362200096,0.0310940020362775,0.0216201655877545,"AKT2/TP53",2
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/36","32/2914",0.00671805808984908,0.0329109362603843,0.0228835095195332,"JUN/TP53/EGR1",3
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","4/36","63/2914",0.00695959782964809,0.0337153850414063,0.0234428558472357,"AKT2/EGFR/SRC/CREB1",4
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","3/36","33/2914",0.00732762028709898,0.0342108601765554,0.0237873677712409,"MAPK11/MAPK14/ITCH",3
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/36","33/2914",0.00732762028709898,0.0342108601765554,0.0237873677712409,"MAPK11/MAPK14/SRC",3
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","2/36","11/2914",0.00761113173652724,0.0342108601765554,0.0237873677712409,"PPP2CA/E2F1",2
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","2/36","11/2914",0.00761113173652724,0.0342108601765554,0.0237873677712409,"RHOA/ROCK2",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/36","11/2914",0.00761113173652724,0.0342108601765554,0.0237873677712409,"SMAD2/STAT3",2
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","2/36","11/2914",0.00761113173652724,0.0342108601765554,0.0237873677712409,"RHOA/ROCK2",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/36","11/2914",0.00761113173652724,0.0342108601765554,0.0237873677712409,"TP53/E2F1",2
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","3/36","34/2914",0.0079690764744257,0.0354542586005062,0.024651922928406,"RHOA/ROCK2/SRC",3
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","3/36","35/2914",0.00864281427847138,0.0380633032870053,0.0264660341541707,"AKT2/SFN/TP53",3
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/36","12/2914",0.00906273497511956,0.0395135244915213,0.0274743965561519,"SMAD2/SMAD3",2
"R-HSA-422475","R-HSA-422475","Axon guidance","8/36","254/2914",0.0104598145193603,0.0451532587172385,0.031395795534922,"EGFR/MAPK11/MAPK14/MAPK8/RHOA/ROCK2/SRC/CREB1",8
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","3/36","38/2914",0.0108611887415919,0.046426257758177,0.0322809324827498,"MAPK11/MAPK14/CREB1",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/36","14/2914",0.012303310193546,0.0509648327032647,0.0354366774952686,"PPP2CA/SRC",2
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","2/36","14/2914",0.012303310193546,0.0509648327032647,0.0354366774952686,"EGFR/RHOA",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/36","14/2914",0.012303310193546,0.0509648327032647,0.0354366774952686,"AKT2/TP53",2
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","3/36","40/2914",0.0125074245395627,0.0509648327032647,0.0354366774952686,"PPP2CA/SRC/E2F1",3
"R-HSA-69236","R-HSA-69236","G1 Phase","3/36","40/2914",0.0125074245395627,0.0509648327032647,0.0354366774952686,"PPP2CA/SRC/E2F1",3
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","4/36","77/2914",0.0139852896995829,0.0538750861886212,0.0374602241002485,"AKT2/PPP2CA/SRC/E2F1",4
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","2/36","15/2914",0.0140866051043643,0.0538750861886212,0.0374602241002485,"AKT2/SFN",2
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/36","15/2914",0.0140866051043643,0.0538750861886212,0.0374602241002485,"SMAD2/SMAD3",2
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","2/36","15/2914",0.0140866051043643,0.0538750861886212,0.0374602241002485,"RHOA/ROCK2",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/36","15/2914",0.0140866051043643,0.0538750861886212,0.0374602241002485,"MAPK14/PPP2CA",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/36","15/2914",0.0140866051043643,0.0538750861886212,0.0374602241002485,"SFN/TP53",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/36","15/2914",0.0140866051043643,0.0538750861886212,0.0374602241002485,"SMAD3/STAT3",2
"R-HSA-1643685","R-HSA-1643685","Disease","11/36","443/2914",0.0145210981474345,0.0550539025415778,0.0382798742925505,"AKT2/EGFR/JUN/SMAD2/NR4A1/PPP2CA/SMAD3/SRC/STAT3/CREB1/FOXO1",11
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","2/36","16/2914",0.0159748695007674,0.0595302829259366,0.0413923744149438,"AKT2/RHOA",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/36","16/2914",0.0159748695007674,0.0595302829259366,0.0413923744149438,"MAPK11/MAPK14",2
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","2/36","17/2914",0.01796538773635,0.0658227651516689,0.0457676396998567,"EGFR/SRC",2
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","2/36","17/2914",0.01796538773635,0.0658227651516689,0.0457676396998567,"MAPK14/SRC",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/36","46/2914",0.018269460033706,0.0663790381224652,0.04615442534831,"NR4A1/HNF4A/NR2F1",3
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","7/36","228/2914",0.0192208644036684,0.0680426173257446,0.0473111390386636,"MAPK11/MAPK14/SFN/PPP2CA/RHOA/ROCK2/SRC",7
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","3/36","47/2914",0.01935157006512,0.0680426173257446,0.0473111390386636,"PPP2CA/RHOA/SRC",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/36","47/2914",0.01935157006512,0.0680426173257446,0.0473111390386636,"EGFR/RHOA/STAT3",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/36","47/2914",0.01935157006512,0.0680426173257446,0.0473111390386636,"EGFR/RHOA/STAT3",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/36","18/2914",0.0200554920046457,0.0699535561122041,0.0486398458723196,"EGFR/CREB1",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","3/36","48/2914",0.0204687649026527,0.0708284245837825,0.0492481561567585,"MAPK11/MAPK14/ITCH",3
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","3/36","49/2914",0.021621110413644,0.074226804254715,0.0516111048415208,"SRC/STAT3/STAT6",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/36","20/2914",0.0245240223303338,0.0835349510626994,0.0580832107823694,"SMAD2/SMAD3",2
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","3/36","53/2914",0.0265826815748701,0.089520936447093,0.0622453638260811,"AKT2/PPP2CA/SRC",3
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","2/36","21/2914",0.0268973455838743,0.089520936447093,0.0622453638260811,"AKT2/RHOA",2
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/36","21/2914",0.0268973455838743,0.089520936447093,0.0622453638260811,"MAPK11/MAPK14",2
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/36","22/2914",0.0293600478794034,0.0962479765069165,0.066922784244307,"SMAD2/SMAD3",2
"R-HSA-525793","R-HSA-525793","Myogenesis","2/36","22/2914",0.0293600478794034,0.0962479765069165,0.066922784244307,"MAPK11/MAPK14",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","10/36","428/2914",0.0300141840867364,0.0976580915060976,0.0679032601490973,"JUN/MAPK11/MAPK14/ITCH/MAPK8/PPP2CA/RHOA/SRC/STAT6/CREB1",10
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/36","56/2914",0.0306735371308057,0.0990641643631946,0.0688809254867215,"MAPK11/MAPK14/TP53",3
"R-HSA-392518","R-HSA-392518","Signal amplification","2/36","23/2914",0.0319096900702368,0.102154507019609,0.0710296910228086,"MAPK14/SRC",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","4/36","99/2914",0.0320990079396477,0.102154507019609,0.0710296910228086,"AKT2/EGFR/PPP2CA/SRC",4
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/36","24/2914",0.0345438766996172,0.108353454971461,0.0753399204050719,"SFN/RHOA",2
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","2/36","24/2914",0.0345438766996172,0.108353454971461,0.0753399204050719,"AKT2/EGFR",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/36","60/2914",0.036618260162636,0.114039724506495,0.0792936761416479,"AKT2/PPP2CA/E2F1",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/36","26/2914",0.0400565159501417,0.123862701803275,0.086123752098849,"AKT2/SFN",2
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/36","27/2914",0.0429303902189167,0.129087242313432,0.0897564601310201,"YAP1/SRC",2
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/36","27/2914",0.0429303902189167,0.129087242313432,0.0897564601310201,"AKT2/RPS6KB1",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/36","27/2914",0.0429303902189167,0.129087242313432,0.0897564601310201,"PPP2CA/SRC",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/36","27/2914",0.0429303902189167,0.129087242313432,0.0897564601310201,"TP53/RHOA",2
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/36","28/2914",0.0458796509473545,0.136078420496916,0.0946175400847699,"SMAD2/SMAD3",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/36","28/2914",0.0458796509473545,0.136078420496916,0.0946175400847699,"PPP2CA/SRC",2
"R-HSA-5673000","R-HSA-5673000","RAF activation","2/36","29/2914",0.0489021114171851,0.144062976877653,0.100169332063651,"PPP2CA/SRC",2
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","3/36","68/2914",0.0501602780962453,0.145799208333086,0.101376562047148,"RHOA/ROCK2/SRC",3
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","3/36","68/2914",0.0501602780962453,0.145799208333086,0.101376562047148,"TP53/PPP2CA/E2F1",3
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/36","30/2914",0.0519956247767434,0.148170538579478,0.103025386554538,"JUN/MAPK8",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/36","30/2914",0.0519956247767434,0.148170538579478,0.103025386554538,"TP53/STAT3",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/36","30/2914",0.0519956247767434,0.148170538579478,0.103025386554538,"PPP2CA/SRC",2
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","2/36","31/2914",0.0551580834338077,0.154159771648334,0.107189797766104,"AKT2/SRC",2
"R-HSA-391251","R-HSA-391251","Protein folding","2/36","31/2914",0.0551580834338077,0.154159771648334,0.107189797766104,"TP53/STAT3",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/36","31/2914",0.0551580834338077,0.154159771648334,0.107189797766104,"MAPK11/MAPK14",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/36","32/2914",0.0583874184567382,0.161119711690746,0.112029157332049,"SRC/CREB1",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/36","32/2914",0.0583874184567382,0.161119711690746,0.112029157332049,"PPP2CA/SRC",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","4/36","124/2914",0.0643641022882512,0.175042243181004,0.121709720029284,"SMAD2/TP53/RHOA/SMAD3",4
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/36","34/2914",0.0650386316406484,0.175042243181004,0.121709720029284,"JUN/FOXO1",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/36","34/2914",0.0650386316406484,0.175042243181004,0.121709720029284,"TP53/MAPK8",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/36","34/2914",0.0650386316406484,0.175042243181004,0.121709720029284,"JUN/TP53",2
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/36","35/2914",0.0684565599656288,0.18311079843567,0.127319917792064,"TP53/MAPK8",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/36","80/2914",0.0744181301019662,0.196644271057317,0.136729961527057,"MAPK11/MAPK14/CREB1",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/36","80/2914",0.0744181301019662,0.196644271057317,0.136729961527057,"SMAD2/TP53/SMAD3",3
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/36","37/2914",0.0754674589449694,0.198215735542209,0.137822626354795,"PPP2CA/SRC",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","3/36","82/2914",0.0788952452293896,0.203956920318472,0.141814565552197,"MAPK8/SMAD3/STAT3",3
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/36","38/2914",0.0790566961784905,0.203956920318472,0.141814565552197,"RHOA/ROCK2",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/36","38/2914",0.0790566961784905,0.203956920318472,0.141814565552197,"PPP2CA/SRC",2
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","6/36","249/2914",0.0813208253734077,0.208563999192975,0.145017942461557,"AKT2/SFN/TP53/PPP2CA/SRC/E2F1",6
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","2/36","39/2914",0.0826993611436384,0.209765582615919,0.145853422968095,"AKT2/E2F1",2
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","5/36","191/2914",0.082751560114537,0.209765582615919,0.145853422968095,"AKT2/TP53/PPP2CA/SRC/E2F1",5
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","2/36","40/2914",0.0863936735964845,0.217732032879001,0.151392625468741,"AKT2/E2F1",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/36","41/2914",0.0901378869205689,0.224572106842103,0.156148640199241,"SRC/STAT3",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/36","41/2914",0.0901378869205689,0.224572106842103,0.156148640199241,"PPP2CA/SRC",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/36","42/2914",0.0939302876054808,0.231376301672258,0.160879707584766,"MAPK14/PPP2CA",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/36","42/2914",0.0939302876054808,0.231376301672258,0.160879707584766,"EGR1/IRF4",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","4/36","144/2914",0.0991400499226097,0.242653206008581,0.168720722671346,"AKT2/EGFR/SFN/SRC",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","5/36","202/2914",0.0996213850356331,0.242653206008581,0.168720722671346,"EGFR/JUN/PPP2CA/SRC/FOXO1",5
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","2/36","44/2914",0.101652959468276,0.246226057378713,0.171204984367623,"EGFR/SRC",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","3/36","92/2914",0.102993020828802,0.248093685532364,0.172503576613522,"EGFR/PPP2CA/SRC",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","2/36","45/2914",0.105579964563243,0.252927827195462,0.175864833974633,"JUN/STAT3",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/36","46/2914",0.10954862386004,0.261001092912446,0.181478306998514,"SFN/TP53",2
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/36","47/2914",0.113557381806481,0.267228705955198,0.185808467684928,"SRC/CREB1",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/36","10/2914",0.11706578632441,0.267228705955198,0.185808467684928,"E2F1",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/36","10/2914",0.11706578632441,0.267228705955198,0.185808467684928,"SRC",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/36","10/2914",0.11706578632441,0.267228705955198,0.185808467684928,"CREB1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/36","10/2914",0.11706578632441,0.267228705955198,0.185808467684928,"SRC",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/36","10/2914",0.11706578632441,0.267228705955198,0.185808467684928,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/36","10/2914",0.11706578632441,0.267228705955198,0.185808467684928,"STAT3",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/36","10/2914",0.11706578632441,0.267228705955198,0.185808467684928,"FOXO1",1
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/36","49/2914",0.121689121595897,0.269627564142389,0.187476432817499,"SRC/CREB1",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/36","49/2914",0.121689121595897,0.269627564142389,0.187476432817499,"JUN/SP1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/36","50/2914",0.125809141078982,0.269627564142389,0.187476432817499,"PPP2CA/SRC",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"STAT3",1
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"AKT2",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"E2F1",1
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"STAT6",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"SRC",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"CREB1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"STAT3",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"TP53",1
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"SRC",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"TP53",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"SFN",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"EGFR",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/36","11/2914",0.128011251783198,0.269627564142389,0.187476432817499,"STAT3",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","4/36","160/2914",0.132222694366294,0.277159109344731,0.192713238752493,"AKT2/EGFR/SFN/SRC",4
"R-HSA-373760","R-HSA-373760","L1CAM interactions","2/36","53/2914",0.138368627035776,0.278036038564846,0.193322981908922,"EGFR/SRC",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/36","12/2914",0.138824753311206,0.278036038564846,0.193322981908922,"CREB1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/36","12/2914",0.138824753311206,0.278036038564846,0.193322981908922,"STAT3",1
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","1/36","12/2914",0.138824753311206,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/36","12/2914",0.138824753311206,0.278036038564846,0.193322981908922,"CREB1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/36","12/2914",0.138824753311206,0.278036038564846,0.193322981908922,"CREB1",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/36","55/2914",0.146894056603553,0.278036038564846,0.193322981908922,"PPP2CA/SRC",2
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"CREB1",1
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"EGFR",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"AKT2",1
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"MAPK8",1
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"SRC",1
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"SRC",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"TP53",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"SP1",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"EGFR",1
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"AKT2",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/36","13/2914",0.149507837005484,0.278036038564846,0.193322981908922,"FOXO1",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","3/36","109/2914",0.149724570792885,0.278036038564846,0.193322981908922,"MAPK11/MAPK14/PPP2CA",3
"R-HSA-109582","R-HSA-109582","Hemostasis","6/36","298/2914",0.155563288509457,0.278036038564846,0.193322981908922,"MAPK14/TP53/PPP2CA/RHOA/SRC/GATA2",6
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"EGFR",1
"R-HSA-2173791","R-HSA-2173791","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"RHOA",1
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"SP1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"EGFR",1
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"EGFR",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"E2F1",1
"R-HSA-8849471","R-HSA-8849471","PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"RHOA",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"STAT3",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"SRC",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/36","14/2914",0.160062031375634,0.278036038564846,0.193322981908922,"PPP2CA",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/36","59/2914",0.164263685185946,0.283713215401548,0.197270415344388,"PPP2CA/CREB1",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","3/36","114/2914",0.164631751138971,0.283713215401548,0.197270415344388,"SFN/TP53/PPP2CA",3
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/36","15/2914",0.170488847537867,0.28559544862846,0.198579162735385,"SRC",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/36","15/2914",0.170488847537867,0.28559544862846,0.198579162735385,"TP53",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/36","15/2914",0.170488847537867,0.28559544862846,0.198579162735385,"E2F1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/36","15/2914",0.170488847537867,0.28559544862846,0.198579162735385,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/36","15/2914",0.170488847537867,0.28559544862846,0.198579162735385,"JUN",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/36","15/2914",0.170488847537867,0.28559544862846,0.198579162735385,"JUN",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/36","15/2914",0.170488847537867,0.28559544862846,0.198579162735385,"SRC",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","2/36","61/2914",0.173088095695117,0.28559544862846,0.198579162735385,"RHOA/ROCK2",2
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","2/36","62/2914",0.177531067149658,0.28559544862846,0.198579162735385,"SRC/STAT3",2
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","2/36","62/2914",0.177531067149658,0.28559544862846,0.198579162735385,"SFN/TP53",2
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/36","62/2914",0.177531067149658,0.28559544862846,0.198579162735385,"TP53/GATA2",2
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"EGFR",1
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"RPS6KB1",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"PPP2CA",1
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"EGFR",1
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"EGFR",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"TP53",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"SRC",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"SRC",1
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"EGFR",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"TP53",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"SRC",1
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","1/36","16/2914",0.180789779407007,0.28559544862846,0.198579162735385,"SRC",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","2/36","64/2914",0.186472908402279,0.293509704199978,0.204082073417657,"RHOA/SRC",2
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/36","17/2914",0.190966303886423,0.299501109692375,0.208247995150662,"SMAD3",1
"R-HSA-69275","R-HSA-69275","G2/M Transition","2/36","66/2914",0.195482038864772,0.305484476505522,0.212408327459175,"TP53/PPP2CA",2
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","4/36","188/2914",0.199502842591445,0.309698473994309,0.215338388484696,"AKT2/EGFR/PPP2CA/SRC",4
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/36","18/2914",0.201019881055939,0.309698473994309,0.215338388484696,"ITCH",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/36","18/2914",0.201019881055939,0.309698473994309,0.215338388484696,"PPP2CA",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/36","18/2914",0.201019881055939,0.309698473994309,0.215338388484696,"E2F1",1
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/36","19/2914",0.21095195435773,0.322719481052528,0.224392106574428,"E2F1",1
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/36","19/2914",0.21095195435773,0.322719481052528,0.224392106574428,"SRC",1
"R-HSA-69242","R-HSA-69242","S Phase","2/36","71/2914",0.218245148029318,0.3285088141303,0.228417524069354,"AKT2/E2F1",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/36","20/2914",0.220763950780225,0.3285088141303,0.228417524069354,"SP1",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/36","20/2914",0.220763950780225,0.3285088141303,0.228417524069354,"SRC",1
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","1/36","20/2914",0.220763950780225,0.3285088141303,0.228417524069354,"EGFR",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/36","20/2914",0.220763950780225,0.3285088141303,0.228417524069354,"MAPK8",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/36","20/2914",0.220763950780225,0.3285088141303,0.228417524069354,"PPP2CA",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/36","20/2914",0.220763950780225,0.3285088141303,0.228417524069354,"PPP2CA",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/36","20/2914",0.220763950780225,0.3285088141303,0.228417524069354,"EGFR",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","2/36","72/2914",0.222831145916858,0.330457073536565,0.229772180537254,"EGFR/SRC",2
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/36","21/2914",0.230457281040042,0.340608049265961,0.236830319141952,"AKT2",1
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"EGFR",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"STAT3",1
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"EGFR",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"PPP2CA",1
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"CREB1",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"TP53",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/36","22/2914",0.240033339761977,0.345394508700403,0.240158422273578,"CREB1",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","2/36","76/2914",0.241255878303618,0.346011720198611,0.240587579471752,"MAPK8/RHOA",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/36","77/2914",0.245877939811838,0.351484530353971,0.24439291342816,"SRC/CREB1",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/36","23/2914",0.249493505657056,0.354329538978751,0.246371094219894,"STAT3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/36","23/2914",0.249493505657056,0.354329538978751,0.246371094219894,"E2F1",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/36","24/2914",0.258839141698684,0.361711108271238,0.251503619464308,"STAT3",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/36","24/2914",0.258839141698684,0.361711108271238,0.251503619464308,"TP53",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/36","24/2914",0.258839141698684,0.361711108271238,0.251503619464308,"TP53",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/36","24/2914",0.258839141698684,0.361711108271238,0.251503619464308,"STAT3",1
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","1/36","24/2914",0.258839141698684,0.361711108271238,0.251503619464308,"STAT3",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/36","81/2914",0.264405259943408,0.361855156499842,0.251603778541657,"TP53/MAPK8",2
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"CREB1",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"CREB1",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"SRC",1
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"SRC",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"AKT2",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"EGFR",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"AKT2",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"SRC",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"SRC",1
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","1/36","25/2914",0.268071595296901,0.361855156499842,0.251603778541657,"AKT2",1
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/36","26/2914",0.277192198470772,0.369589597961029,0.256981661547022,"CREB1",1
"R-HSA-182971","R-HSA-182971","EGFR downregulation","1/36","26/2914",0.277192198470772,0.369589597961029,0.256981661547022,"EGFR",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/36","26/2914",0.277192198470772,0.369589597961029,0.256981661547022,"RUNX2",1
"R-HSA-936440","R-HSA-936440","Negative regulators of DDX58/IFIH1 signaling","1/36","26/2914",0.277192198470772,0.369589597961029,0.256981661547022,"ITCH",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/36","27/2914",0.28620226801892,0.376921475053146,0.26207963499591,"ITCH",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/36","27/2914",0.28620226801892,0.376921475053146,0.26207963499591,"JUN",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/36","27/2914",0.28620226801892,0.376921475053146,0.26207963499591,"JUN",1
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","1/36","27/2914",0.28620226801892,0.376921475053146,0.26207963499591,"SRC",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","7/36","436/2914",0.287013600269827,0.376921475053146,0.26207963499591,"AKT2/EGFR/PPP2CA/RHOA/ROCK2/SRC/CREB1",7
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/36","87/2914",0.292231155776444,0.381784509418509,0.265460981923058,"JUN/MAPK8",2
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","3/36","153/2914",0.292467949875647,0.381784509418509,0.265460981923058,"MAPK14/RHOA/SRC",3
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/36","28/2914",0.295103105688237,0.382931410952594,0.26625844122247,"RHOA",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/36","28/2914",0.295103105688237,0.382931410952594,0.26625844122247,"SP1",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/36","88/2914",0.296863921946766,0.384073204655163,0.267052348963513,"SRC/CREB1",2
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","1/36","29/2914",0.303895998340775,0.389701927284052,0.270966091399824,"PPP2CA",1
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","1/36","29/2914",0.303895998340775,0.389701927284052,0.270966091399824,"PPP2CA",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/36","29/2914",0.303895998340775,0.389701927284052,0.270966091399824,"CREB1",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/36","30/2914",0.312582218118845,0.3973348311948,0.276273373694115,"CREB1",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/36","30/2914",0.312582218118845,0.3973348311948,0.276273373694115,"PPP2CA",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/36","30/2914",0.312582218118845,0.3973348311948,0.276273373694115,"TP53",1
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","1/36","31/2914",0.321163022608346,0.40470253715965,0.281396259541234,"AKT2",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/36","31/2914",0.321163022608346,0.40470253715965,0.281396259541234,"PPP2CA",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/36","31/2914",0.321163022608346,0.40470253715965,0.281396259541234,"STAT3",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/36","32/2914",0.329639655000333,0.410636827371844,0.285522468090514,"CREB1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/36","32/2914",0.329639655000333,0.410636827371844,0.285522468090514,"STAT3",1
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","1/36","32/2914",0.329639655000333,0.410636827371844,0.285522468090514,"SRC",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/36","32/2914",0.329639655000333,0.410636827371844,0.285522468090514,"SRC",1
"R-HSA-5632684","R-HSA-5632684","Hedgehog 'on' state","1/36","33/2914",0.33801334425085,0.4167215062623,0.289753244334965,"ITCH",1
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","1/36","33/2914",0.33801334425085,0.4167215062623,0.289753244334965,"PPP2CA",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/36","33/2914",0.33801334425085,0.4167215062623,0.289753244334965,"SRC",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/36","97/2914",0.338347278020308,0.4167215062623,0.289753244334965,"EGR1/IRF4",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/36","34/2914",0.346285305239038,0.419389980789501,0.291608678096032,"CREB1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/36","34/2914",0.346285305239038,0.419389980789501,0.291608678096032,"CREB1",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/36","34/2914",0.346285305239038,0.419389980789501,0.291608678096032,"STAT6",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/36","34/2914",0.346285305239038,0.419389980789501,0.291608678096032,"PPP2CA",1
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","1/36","34/2914",0.346285305239038,0.419389980789501,0.291608678096032,"SRC",1
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","1/36","34/2914",0.346285305239038,0.419389980789501,0.291608678096032,"PPP2CA",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/36","35/2914",0.35445673892355,0.426035588918264,0.296229477567504,"WWTR1",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/36","35/2914",0.35445673892355,0.426035588918264,0.296229477567504,"ITCH",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","3/36","171/2914",0.354703942149839,0.426035588918264,0.296229477567504,"EGFR/PPP2CA/SRC",3
"R-HSA-195721","R-HSA-195721","Signaling by WNT","3/36","172/2914",0.358164798224802,0.429010582489049,0.298298039007354,"AKT2/PPP2CA/RHOA",3
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","1/36","36/2914",0.362528832497274,0.43304813964058,0.301105418195285,"SRC",1
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","1/36","37/2914",0.370502759540393,0.440161316511203,0.306051325821406,"PPP2CA",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/36","37/2914",0.370502759540393,0.440161316511203,0.306051325821406,"EGFR",1
"R-HSA-112316","R-HSA-112316","Neuronal System","2/36","105/2914",0.374683555276682,0.443612564294275,0.308451034564827,"SRC/CREB1",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","3/36","177/2914",0.375442743634375,0.443612564294275,0.308451034564827,"EGFR/PPP2CA/SRC",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","2/36","106/2914",0.379177228813543,0.44681424800731,0.310677217349361,"MAPK8/RHOA",2
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","2/36","108/2914",0.388127795701353,0.456128622441482,0.317153653460036,"AKT2/PPP2CA",2
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","7/36","486/2914",0.393796411925098,0.460368164213922,0.320101475841646,"AKT2/EGFR/PPP2CA/RHOA/ROCK2/SRC/CREB1",7
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","1/36","40/2914",0.39384707626558,0.460368164213922,0.320101475841646,"SMAD3",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/36","41/2914",0.401439805999206,0.465529651790197,0.32369034214287,"STAT3",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/36","41/2914",0.401439805999206,0.465529651790197,0.32369034214287,"CREB1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"AKT2",1
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"SRC",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"STAT3",1
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"SRC",1
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"SRC",1
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"SRC",1
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"PPP2CA",1
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","1/36","42/2914",0.40894003815515,0.465529651790197,0.32369034214287,"SRC",1
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","1/36","44/2914",0.423667377255615,0.479789549307657,0.33360548092855,"RHOA",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/36","44/2914",0.423667377255615,0.479789549307657,0.33360548092855,"PPP2CA",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/36","45/2914",0.430896636634987,0.48671226314211,0.338418956506344,"STAT3",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/36","46/2914",0.438037703585541,0.492227934956948,0.342254092872045,"AKT2",1
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","1/36","46/2914",0.438037703585541,0.492227934956948,0.342254092872045,"SRC",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/36","47/2914",0.445091623624216,0.497589610000406,0.345982152776719,"SP1",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/36","47/2914",0.445091623624216,0.497589610000406,0.345982152776719,"IRF4",1
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","1/36","48/2914",0.452059430233748,0.502800794851822,0.349605574402039,"MAPK8",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/36","48/2914",0.452059430233748,0.502800794851822,0.349605574402039,"SP1",1
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","1/36","49/2914",0.458942144997037,0.509157188851674,0.354025278583492,"SRC",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/36","125/2914",0.461862888139764,0.511097003119129,0.355374063008955,"MAPK14/RHOA",2
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/36","50/2914",0.465740777730058,0.514083491367862,0.357450616885428,"AKT2",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/36","51/2914",0.47245632661334,0.517565222119136,0.359871520932668,"AKT2",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/36","51/2914",0.47245632661334,0.517565222119136,0.359871520932668,"AKT2",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/36","51/2914",0.47245632661334,0.517565222119136,0.359871520932668,"E2F1",1
"R-HSA-400253","R-HSA-400253","Circadian Clock","1/36","52/2914",0.479089778322009,0.520905594385027,0.362194136124789,"CREB1",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","1/36","52/2914",0.479089778322009,0.520905594385027,0.362194136124789,"AKT2",1
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","1/36","52/2914",0.479089778322009,0.520905594385027,0.362194136124789,"AKT2",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/36","53/2914",0.485642108154437,0.522814713963789,0.36352157803373,"SRC",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/36","53/2914",0.485642108154437,0.522814713963789,0.36352157803373,"WWTR1",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/36","53/2914",0.485642108154437,0.522814713963789,0.36352157803373,"SRC",1
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","1/36","53/2914",0.485642108154437,0.522814713963789,0.36352157803373,"EGFR",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/36","55/2914",0.498507247262372,0.53402741967173,0.371317954769334,"PPP2CA",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/36","55/2914",0.498507247262372,0.53402741967173,0.371317954769334,"ITCH",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","1/36","56/2914",0.504821951389183,0.53699358658684,0.373380378891864,"PPP2CA",1
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","1/36","56/2914",0.504821951389183,0.53699358658684,0.373380378891864,"PPP2CA",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","4/36","296/2914",0.504971033258267,0.53699358658684,0.373380378891864,"AKT2/ITCH/PPP2CA/SRC",4
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","3/36","217/2914",0.509128837264023,0.54009774464018,0.375538750498242,"PPP2CA/SRC/CREB1",3
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/36","57/2914",0.511059323590019,0.540829769624389,0.376047739381516,"SRC",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/36","60/2914",0.529316598546842,0.558794278369063,0.388538754636142,"PPP2CA",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/36","61/2914",0.535253740261037,0.560987093158202,0.390063454441242,"MAPK8",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/36","61/2914",0.535253740261037,0.560987093158202,0.390063454441242,"PPP2CA",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/36","61/2914",0.535253740261037,0.560987093158202,0.390063454441242,"SRC",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","1/36","62/2914",0.541118046377617,0.56577330508547,0.393391385477101,"SRC",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/36","64/2914",0.552631614993635,0.576429148653648,0.400800566905482,"ITCH",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/36","66/2914",0.563864130916671,0.585344669237306,0.406999673443612,"ITCH",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","1/36","66/2914",0.563864130916671,0.585344669237306,0.406999673443612,"EGFR",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/36","69/2914",0.580200477958741,0.600872704014278,0.417796568701381,"SRC",1
"R-HSA-73894","R-HSA-73894","DNA Repair","2/36","157/2914",0.586235935491135,0.605684521028755,0.421142303371032,"TP53/MAPK8",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","1/36","72/2914",0.595941290347957,0.614256270902386,0.427102380540529,"SRC",1
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/36","73/2914",0.601059556902311,0.618070676437282,0.429754598778216,"SRC",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/36","165/2914",0.613996960271864,0.62988864630243,0.437971825531386,"EGFR/CREB1",2
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/36","76/2914",0.616039037170074,0.630500047432283,0.438396942685894,"RHOA",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/36","88/2914",0.670674140988995,0.684810129909138,0.476159626783756,"ITCH",1
"R-HSA-68886","R-HSA-68886","M Phase","1/36","105/2914",0.735332954277924,0.747630305426359,0.519839517051645,"PPP2CA",1
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","4/36","393/2914",0.73562706657777,0.747630305426359,0.519839517051645,"SMAD2/TP53/RHOA/SMAD3",4
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","1/36","106/2914",0.738724913568061,0.749032703059709,0.520814626946393,"RHOA",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","1/36","107/2914",0.742074594163342,0.750683348155956,0.52196234734166,"TP53",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","1/36","109/2914",0.748649161662302,0.75558109834436,0.525367832745475,"TP53",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/36","115/2914",0.767410210786516,0.772727140653397,0.537289754969045,"ITCH",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","1/36","119/2914",0.779153535595649,0.782744104884109,0.544254713198028,"SP1",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/36","126/2914",0.798331984168985,0.800167230109604,0.556369295682197,"SRC",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","2/36","289/2914",0.885962468869442,0.885962468869442,0.616024121280539,"PPP2CA/SP1",2
